<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EDB67137-AF95-475C-954C-8EA1517069D6"><gtr:id>EDB67137-AF95-475C-954C-8EA1517069D6</gtr:id><gtr:name>Nat Inst for Bio Standards and Control</gtr:name><gtr:department>Laboratory for Molecular Studies</gtr:department><gtr:address><gtr:line1>Blanche Lane</gtr:line1><gtr:line2>South Mimms</gtr:line2><gtr:line4>Potters Bar</gtr:line4><gtr:line5>Hertfordshire</gtr:line5><gtr:postCode>EN6 3QG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EDB67137-AF95-475C-954C-8EA1517069D6"><gtr:id>EDB67137-AF95-475C-954C-8EA1517069D6</gtr:id><gtr:name>Nat Inst for Bio Standards and Control</gtr:name><gtr:address><gtr:line1>Blanche Lane</gtr:line1><gtr:line2>South Mimms</gtr:line2><gtr:line4>Potters Bar</gtr:line4><gtr:line5>Hertfordshire</gtr:line5><gtr:postCode>EN6 3QG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7EFA5362-8D9A-4594-B971-1B08DA3CC68E"><gtr:id>7EFA5362-8D9A-4594-B971-1B08DA3CC68E</gtr:id><gtr:firstName>Kenneth</gtr:firstName><gtr:otherNames>Barry</gtr:otherNames><gtr:surname>Walker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6FC4BB73-A97A-4E27-AF06-39D123FB1570"><gtr:id>6FC4BB73-A97A-4E27-AF06-39D123FB1570</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Mark</gtr:otherNames><gtr:surname>Almond</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/707D54B5-47E1-4C9E-A00D-C2C53DBA3115"><gtr:id>707D54B5-47E1-4C9E-A00D-C2C53DBA3115</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:otherNames>Mary</gtr:otherNames><gtr:surname>Wade-Evans</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FDB7E018-B665-4357-883B-CDCDA5CBB63A"><gtr:id>FDB7E018-B665-4357-883B-CDCDA5CBB63A</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Stebbings</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9025730"><gtr:id>61072F5B-58A4-4271-A159-E683B47E4C26</gtr:id><gtr:title>The characterisation of vaccine protection: models of AIDS vaccine development</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9025730</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1991-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>9984569</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Investigation of recombinant measles virus vectors as AIDS Vaccine</gtr:description><gtr:id>FC4E4331-E2D7-454C-AEE1-6FDC702E1FE6</gtr:id><gtr:impact>The design of a Phase 1 clinical trial of recombinant measles virus expressing HIV antigens has been modified based upon outcome of pre-clinical immunogenicity study performed by us</gtr:impact><gtr:outcomeId>C8B197633C0-1</gtr:outcomeId><gtr:partnerContribution>Partner is producing novel measles virus vectors that will allow further questions about vaccine protection to be explored.</gtr:partnerContribution><gtr:piContribution>HAving an established NHP model of HIV/AIDS for evaluating serological and T cell responses following vaccination.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Neuroinflammation and Neurocognitive Decline in HIV</gtr:description><gtr:id>B29A8516-12C0-4C4D-BF1C-95A941A1133C</gtr:id><gtr:impact>Submission to Wellcome Trust for Strategic Award. The award was ultimately declined</gtr:impact><gtr:outcomeId>AP1ZYg9UmAR-1</gtr:outcomeId><gtr:partnerContribution>Imperial College at St Mary's Hospital provide comparative clinical data from HIV infected individuals on Anti-Retroviral Therapies but developing Neurocognitive decline.
Dept of Experimental Psychology, University of Oxford bring expertise in MRI and measuring neurocognitive capacity of NHP's</gtr:partnerContribution><gtr:piContribution>Characterising the neuropathology following infection with attenuated SIV including doxycycline dependent SIV in an NHP model of HIV/AIDS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Establishing Dox dependent SIV Model</gtr:description><gtr:id>97746C6D-81B4-4BE2-80E0-0CCCA3A574BD</gtr:id><gtr:impact>Successful award of grant from International AIDS Vaccine Initiative. Successful award of grant from MRC G0601201</gtr:impact><gtr:outcomeId>3183E119FA2-1</gtr:outcomeId><gtr:partnerContribution>They have supplied doxycycline dependent simian immunodeficiency virus to evaulate the role of persisting replication for the protection conferred with live attenuated SIV vaccines</gtr:partnerContribution><gtr:piContribution>The established models of protection conferred by live attenuated SIV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Experimental Psychology</gtr:department><gtr:description>Neuroinflammation and Neurocognitive Decline in HIV</gtr:description><gtr:id>6E607A27-4921-4C31-813B-62145C94EAD6</gtr:id><gtr:impact>Submission to Wellcome Trust for Strategic Award. The award was ultimately declined</gtr:impact><gtr:outcomeId>AP1ZYg9UmAR-2</gtr:outcomeId><gtr:partnerContribution>Imperial College at St Mary's Hospital provide comparative clinical data from HIV infected individuals on Anti-Retroviral Therapies but developing Neurocognitive decline.
Dept of Experimental Psychology, University of Oxford bring expertise in MRI and measuring neurocognitive capacity of NHP's</gtr:partnerContribution><gtr:piContribution>Characterising the neuropathology following infection with attenuated SIV including doxycycline dependent SIV in an NHP model of HIV/AIDS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>668000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2010-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1A615C0B-6D13-4E2D-8D68-C2A2EF2939D1</gtr:id><gtr:outcomeId>8A152D4CC2A0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IAVI Programme Grant</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>International AIDS Vaccine Initiative (IAVI)</gtr:fundingOrg><gtr:id>4EE38631-8809-4E03-A404-74C99C7CA1FE</gtr:id><gtr:outcomeId>330084C43E30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Consortium Programme Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>D4D2164D-CB5F-4FC5-A8DD-76A15BA3CA35</gtr:id><gtr:outcomeId>5D2D0594D830</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New stocks of Simian Immunodeficiency Virus that are designed to replicate at higher titre and prolonged time in Mauritian derived cynomolgus macaques</gtr:description><gtr:id>11BA2276-9C3F-40FE-B237-0B8A384EBEF2</gtr:id><gtr:impact>Publication of paper that demonstrates that a more potent replicating SIV can breakthrough protection conferred by Live Attenuated SIV even though it is genetically almost identicial to the vaccine virus.</gtr:impact><gtr:outcomeId>04D41DA4853</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>SIVmacL28 and SIVmacJ5 S61MLN</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>82DBF8AE-1397-4476-A7A0-80F264D55230</gtr:id><gtr:title>The production, characterisation and application of monoclonal antibodies generated by immunisation with HIV-1C clade RGP140 envelope protein.</gtr:title><gtr:parentPublicationTitle>Journal of virological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fbd0dcb40fb4688b1476dd0fa22e4cf"><gtr:id>4fbd0dcb40fb4688b1476dd0fa22e4cf</gtr:id><gtr:otherNames>Hassall M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0166-0934</gtr:issn><gtr:outcomeId>pm_14069_29_23973741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F7A476C-0363-4650-B23A-8E59E3266FE8</gtr:id><gtr:title>Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccine.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c19689ee331bac7aecb68c4f25c1a58"><gtr:id>6c19689ee331bac7aecb68c4f25c1a58</gtr:id><gtr:otherNames>Page M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>18586865BA6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2279470C-BFDB-40C3-A69D-E280BC8B0B8C</gtr:id><gtr:title>Immunogenicity of a recombinant measles HIV-1 subtype C vaccine.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/242045ab417d294ec99a5f569db09bfe"><gtr:id>242045ab417d294ec99a5f569db09bfe</gtr:id><gtr:otherNames>Stebbings R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_14069_29_24161574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4D0CA07-EAA9-4214-B056-065A94480BD0</gtr:id><gtr:title>Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c19689ee331bac7aecb68c4f25c1a58"><gtr:id>6c19689ee331bac7aecb68c4f25c1a58</gtr:id><gtr:otherNames>Page M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5460894b067da9.02804677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA04CF8A-70C9-4897-8425-06A841BFC47E</gtr:id><gtr:title>Complete Genome Sequence of a Reference Stock of Simian Immunodeficiency Virus RNA (SIVmac251/32H/L28) Determined by Deep Sequencing.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be99268a8d5ba7506f852d69202e4f01"><gtr:id>be99268a8d5ba7506f852d69202e4f01</gtr:id><gtr:otherNames>Jenkins A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58a33f4778a619.21001018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE159557-7928-499A-80E7-388CAE91FFEE</gtr:id><gtr:title>MHC haplotype frequencies in a UK breeding colony of Mauritian cynomolgus macaques mirror those found in a distinct population from the same geographic origin.</gtr:title><gtr:parentPublicationTitle>Journal of medical primatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e461ed539902057e92f9c71754dee6"><gtr:id>12e461ed539902057e92f9c71754dee6</gtr:id><gtr:otherNames>Mee ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0047-2565</gtr:issn><gtr:outcomeId>B9FFE83AACD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DB13FEE-5499-4DD7-85CA-BAA89E890C29</gtr:id><gtr:title>Mucosal immunization in macaques upregulates the innate APOBEC 3G anti-viral factor in CD4(+) memory T cells.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>903D09373D2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A48E9AB-59FC-473F-BC4F-1A6971C6241C</gtr:id><gtr:title>Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissues.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02766ea99fdc02271ba31905900e4123"><gtr:id>02766ea99fdc02271ba31905900e4123</gtr:id><gtr:otherNames>Ferguson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5460831b3df556.07964526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1298791-1FF2-4E35-8540-5F70EC4A46A7</gtr:id><gtr:title>Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02766ea99fdc02271ba31905900e4123"><gtr:id>02766ea99fdc02271ba31905900e4123</gtr:id><gtr:otherNames>Ferguson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>58a33f473fb9a0.15260078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A39D9FD7-7121-42EF-81B4-876B053B1F02</gtr:id><gtr:title>Horizontal acquisition and a broad biodistribution typify simian foamy virus infection in a cohort of Macaca fascicularis.</gtr:title><gtr:parentPublicationTitle>Virology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a871e4edd86720363b85cd5525f8bbe7"><gtr:id>a871e4edd86720363b85cd5525f8bbe7</gtr:id><gtr:otherNames>Hood S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1743-422X</gtr:issn><gtr:outcomeId>5460831b8ff377.72691846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89B78DC3-A994-4427-82EF-2D0DEB736FB7</gtr:id><gtr:title>Characterisation of MHC haplotypes in a breeding colony of Indonesian cynomolgus macaques reveals a high level of diversity.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8106cc52ff6d6c564631dd1f147da90d"><gtr:id>8106cc52ff6d6c564631dd1f147da90d</gtr:id><gtr:otherNames>Mitchell JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn><gtr:outcomeId>MmjR8CfJx6A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68357A66-049E-4051-BD9D-27AB7EAE26D5</gtr:id><gtr:title>Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>Journal of neurovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/460297912028122bb9dd14e610a4c745"><gtr:id>460297912028122bb9dd14e610a4c745</gtr:id><gtr:otherNames>Clarke S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1355-0284</gtr:issn><gtr:outcomeId>pm_14069_29_22403025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22D79F0A-21D9-4F4F-A405-9CD3FBD7C524</gtr:id><gtr:title>Immunological responses and viral modulatory effects of vaccination with recombinant modified vaccinia virus Ankara (rMVA) expressing structural and regulatory transgenes of simian immunodeficiency virus (SIVmac32H/J5M).</gtr:title><gtr:parentPublicationTitle>Journal of medical primatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0047-2565</gtr:issn><gtr:outcomeId>7A0D404625C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>593B1B4A-EBE9-406C-BA34-DBA5E1086E20</gtr:id><gtr:title>International multicenter study to assess a panel of reference materials for quantification of simian immunodeficiency virus RNA in plasma.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce0e6cc60fcf8c388fd4f1cec0256300"><gtr:id>ce0e6cc60fcf8c388fd4f1cec0256300</gtr:id><gtr:otherNames>Ham C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>CkPN4ee76X6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48285BF8-A2F3-42FD-99D1-EAAA13FFDF8E</gtr:id><gtr:title>Low rates of transmission of SRV-2 and STLV-I to juveniles in a population of Macaca fascicularis facilitate establishment of specific retrovirus-free colonies.</gtr:title><gtr:parentPublicationTitle>Journal of medical primatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e461ed539902057e92f9c71754dee6"><gtr:id>12e461ed539902057e92f9c71754dee6</gtr:id><gtr:otherNames>Mee ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0047-2565</gtr:issn><gtr:outcomeId>C45CWYJqNE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F29E0C3-26DD-40FC-AC5F-2B64FDD0FB04</gtr:id><gtr:title>Upregulation of TRIM5a gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5a genotype has no impact on virus acquisition or vaccination outcome.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d601c726d34be556fecbbd27cb08186"><gtr:id>2d601c726d34be556fecbbd27cb08186</gtr:id><gtr:otherNames>Mattiuzzo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_14069_29_23152371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A411BB6-613E-411B-8F00-9CFC2E399B48</gtr:id><gtr:title>Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of medical primatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02766ea99fdc02271ba31905900e4123"><gtr:id>02766ea99fdc02271ba31905900e4123</gtr:id><gtr:otherNames>Ferguson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0047-2565</gtr:issn><gtr:outcomeId>787059B1393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80D06391-96A4-45AC-8A41-050B916C89B1</gtr:id><gtr:title>Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>58a33fe6837e78.72812834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B99F3B24-CAFA-4E9F-A6D0-F305038F0FA9</gtr:id><gtr:title>Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>LXEp3iCT5MB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D2085A1-C203-4DB3-A75E-224B8A613C9C</gtr:id><gtr:title>Live attenuated simian immunodeficiency virus vaccination confers superinfection resistance against macrophage-tropic and neurovirulent wild-type SIV challenge.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56e053d2b014b2.55738342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>908B6ECE-7AD8-4F91-B47E-85207BB7D4E2</gtr:id><gtr:title>Mhc haplotype M3 is associated with early control of SHIVsbg infection in Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e461ed539902057e92f9c71754dee6"><gtr:id>12e461ed539902057e92f9c71754dee6</gtr:id><gtr:otherNames>Mee ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>ePkDvbVx74V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDD9B522-19AB-4091-8576-423B9E4325B9</gtr:id><gtr:title>Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e461ed539902057e92f9c71754dee6"><gtr:id>12e461ed539902057e92f9c71754dee6</gtr:id><gtr:otherNames>Mee ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn><gtr:outcomeId>7591AB3AC9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B934CAB-F41B-48B9-9F06-18C7A431871F</gtr:id><gtr:title>Immune Responses in the Central Nervous System Are Anatomically Segregated in a Non-Human Primate Model of Human Immunodeficiency Virus Infection.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c0283dd96b349de1ebf08f918148ca4"><gtr:id>3c0283dd96b349de1ebf08f918148ca4</gtr:id><gtr:otherNames>Tavano B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5aa8e13ec8a9d3.93603546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FA7DA15-D6F9-49F2-843E-27137CF78E63</gtr:id><gtr:title>A sensitive cell-based assay to measure the doxycycline concentration in biological samples.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dabefbe1c40d9b4e1d6130bef59756e"><gtr:id>2dabefbe1c40d9b4e1d6130bef59756e</gtr:id><gtr:otherNames>Kleibeuker W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>982A6AFFDE1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8FC5729-C06D-4F83-B2E1-7AA5589BC2D5</gtr:id><gtr:title>Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c19689ee331bac7aecb68c4f25c1a58"><gtr:id>6c19689ee331bac7aecb68c4f25c1a58</gtr:id><gtr:otherNames>Page M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>pm_14069_29_22799593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE296572-19B6-4048-A611-11C4D3AE5CEB</gtr:id><gtr:title>MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a96081bc737c666c90b62c3f6386d296"><gtr:id>a96081bc737c666c90b62c3f6386d296</gtr:id><gtr:otherNames>O'Connor SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>C4CA0A05_8C4CA0A05_8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F45E358-0AE1-41ED-AF93-7DF849FFB5EC</gtr:id><gtr:title>Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ac15855ba6b861ceec45af3d9639908"><gtr:id>4ac15855ba6b861ceec45af3d9639908</gtr:id><gtr:otherNames>Das AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>ED6575BC58F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EE0D97C-34F7-4AA1-AC09-28920853FF5A</gtr:id><gtr:title>Allogeneic lymphocyte transfer in MHC-identical siblings and MHC-identical unrelated Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e461ed539902057e92f9c71754dee6"><gtr:id>12e461ed539902057e92f9c71754dee6</gtr:id><gtr:otherNames>Mee ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5460831b6808e8.40983599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DB4E2D4-39AB-4E08-9482-124FB9526D5E</gtr:id><gtr:title>Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8).</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5AAD47B04B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9498060-2FA2-42F5-A680-C7DD915AF5FF</gtr:id><gtr:title>Conditionally-live attenuated SIV upregulates global T effector memory cell frequency under replication permissive conditions.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56240d31a307ed3d91893a2f15e9f12a"><gtr:id>56240d31a307ed3d91893a2f15e9f12a</gtr:id><gtr:otherNames>Manoussaka MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>pm_14069_29_23738926</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9025730</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>